 | • レポートコード：GIR-23F3812 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Genito-Urinary Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の泌尿器・生殖器治療薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 泌尿器・生殖器治療薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・OTC、Rxドラッグ アプリケーション別セグメントは次のように区分されます。 ・病院、ドラッグストア、その他 世界の泌尿器・生殖器治療薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Daiichi Sankyo Company、Pfizer、Bayer、Astellas Pharma、Allergan、GSK、Otsuka Pharmaceutical、Sanofi 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 泌尿器・生殖器治療薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：OTC、Rxドラッグ - アプリケーション別分析（2017年vs2021年vs2028年）：病院、ドラッグストア、その他 - 世界の泌尿器・生殖器治療薬市場規模・予測 - 世界の泌尿器・生殖器治療薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Daiichi Sankyo Company、Pfizer、Bayer、Astellas Pharma、Allergan、GSK、Otsuka Pharmaceutical、Sanofi ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：OTC、Rxドラッグ ・アプリケーション別分析2017年-2028年：病院、ドラッグストア、その他 ・泌尿器・生殖器治療薬の北米市場分析 - 泌尿器・生殖器治療薬の北米市場：タイプ別市場規模2017年-2028年 - 泌尿器・生殖器治療薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・泌尿器・生殖器治療薬のヨーロッパ市場分析 - ：泌尿器・生殖器治療薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：泌尿器・生殖器治療薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・泌尿器・生殖器治療薬のアジア太平洋市場分析 - 泌尿器・生殖器治療薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 泌尿器・生殖器治療薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・泌尿器・生殖器治療薬の南米市場分析 - 泌尿器・生殖器治療薬の南米市場：タイプ別市場規模2017年-2028年 - 泌尿器・生殖器治療薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・泌尿器・生殖器治療薬の中東・アフリカ市場分析 - 泌尿器・生殖器治療薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 泌尿器・生殖器治療薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Genito-Urinary Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Genito-Urinary Drugs market size is estimated to be worth US$ 29340 million in 2021 and is forecast to a readjusted size of USD 36470 million by 2028 with a CAGR of 3.2% during review period. Hospital accounting for % of the Genito-Urinary Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While OTC segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Genito-Urinary Drugs include Daiichi Sankyo Company, Pfizer, Bayer, Astellas Pharma, and Allergan, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Genito-Urinary Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
OTC
Rx Drugs
Market segment by Application can be divided into
Hospital
Drugs Store
Other
The key market players for global Genito-Urinary Drugs market are listed below:
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
Allergan
GSK
Otsuka Pharmaceutical
Sanofi
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Genito-Urinary Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Genito-Urinary Drugs, with price, sales, revenue and global market share of Genito-Urinary Drugs from 2019 to 2022.
Chapter 3, the Genito-Urinary Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Genito-Urinary Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Genito-Urinary Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genito-Urinary Drugs.
Chapter 13, 14, and 15, to describe Genito-Urinary Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Genito-Urinary Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Genito-Urinary Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Genito-Urinary Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Genito-Urinary Drugs Market Size & Forecast
1.4.1 Global Genito-Urinary Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Genito-Urinary Drugs Sales in Volume (2017-2028)
1.4.3 Global Genito-Urinary Drugs Price (2017-2028)
1.5 Global Genito-Urinary Drugs Production Capacity Analysis
1.5.1 Global Genito-Urinary Drugs Total Production Capacity (2017-2028)
1.5.2 Global Genito-Urinary Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Genito-Urinary Drugs Market Drivers
1.6.2 Genito-Urinary Drugs Market Restraints
1.6.3 Genito-Urinary Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business
2.1.3 Daiichi Sankyo Company Genito-Urinary Drugs Product and Services
2.1.4 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Genito-Urinary Drugs Product and Services
2.2.4 Pfizer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Genito-Urinary Drugs Product and Services
2.3.4 Bayer Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Astellas Pharma
2.4.1 Astellas Pharma Details
2.4.2 Astellas Pharma Major Business
2.4.3 Astellas Pharma Genito-Urinary Drugs Product and Services
2.4.4 Astellas Pharma Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Allergan
2.5.1 Allergan Details
2.5.2 Allergan Major Business
2.5.3 Allergan Genito-Urinary Drugs Product and Services
2.5.4 Allergan Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 GSK
2.6.1 GSK Details
2.6.2 GSK Major Business
2.6.3 GSK Genito-Urinary Drugs Product and Services
2.6.4 GSK Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Otsuka Pharmaceutical
2.7.1 Otsuka Pharmaceutical Details
2.7.2 Otsuka Pharmaceutical Major Business
2.7.3 Otsuka Pharmaceutical Genito-Urinary Drugs Product and Services
2.7.4 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Sanofi
2.8.1 Sanofi Details
2.8.2 Sanofi Major Business
2.8.3 Sanofi Genito-Urinary Drugs Product and Services
2.8.4 Sanofi Genito-Urinary Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Genito-Urinary Drugs Breakdown Data by Manufacturer
3.1 Global Genito-Urinary Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Genito-Urinary Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Genito-Urinary Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Genito-Urinary Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Genito-Urinary Drugs Manufacturer Market Share in 2021
3.5 Global Genito-Urinary Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Genito-Urinary Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Genito-Urinary Drugs Market Size by Region
4.1.1 Global Genito-Urinary Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Genito-Urinary Drugs Revenue by Region (2017-2028)
4.2 North America Genito-Urinary Drugs Revenue (2017-2028)
4.3 Europe Genito-Urinary Drugs Revenue (2017-2028)
4.4 Asia-Pacific Genito-Urinary Drugs Revenue (2017-2028)
4.5 South America Genito-Urinary Drugs Revenue (2017-2028)
4.6 Middle East and Africa Genito-Urinary Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Genito-Urinary Drugs Sales in Volume by Type (2017-2028)
5.2 Global Genito-Urinary Drugs Revenue by Type (2017-2028)
5.3 Global Genito-Urinary Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Genito-Urinary Drugs Sales in Volume by Application (2017-2028)
6.2 Global Genito-Urinary Drugs Revenue by Application (2017-2028)
6.3 Global Genito-Urinary Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Genito-Urinary Drugs Sales by Type (2017-2028)
7.2 North America Genito-Urinary Drugs Sales by Application (2017-2028)
7.3 North America Genito-Urinary Drugs Market Size by Country
7.3.1 North America Genito-Urinary Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Genito-Urinary Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Genito-Urinary Drugs Sales by Type (2017-2028)
8.2 Europe Genito-Urinary Drugs Sales by Application (2017-2028)
8.3 Europe Genito-Urinary Drugs Market Size by Country
8.3.1 Europe Genito-Urinary Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Genito-Urinary Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Genito-Urinary Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Genito-Urinary Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Genito-Urinary Drugs Market Size by Region
9.3.1 Asia-Pacific Genito-Urinary Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Genito-Urinary Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Genito-Urinary Drugs Sales by Type (2017-2028)
10.2 South America Genito-Urinary Drugs Sales by Application (2017-2028)
10.3 South America Genito-Urinary Drugs Market Size by Country
10.3.1 South America Genito-Urinary Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Genito-Urinary Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Genito-Urinary Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Genito-Urinary Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Genito-Urinary Drugs Market Size by Country
11.3.1 Middle East & Africa Genito-Urinary Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Genito-Urinary Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Genito-Urinary Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Genito-Urinary Drugs
12.3 Genito-Urinary Drugs Production Process
12.4 Genito-Urinary Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Genito-Urinary Drugs Typical Distributors
13.3 Genito-Urinary Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Genito-Urinary Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Genito-Urinary Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Daiichi Sankyo Company Basic Information, Manufacturing Base and Competitors
Table 4. Daiichi Sankyo Company Major Business
Table 5. Daiichi Sankyo Company Genito-Urinary Drugs Product and Services
Table 6. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Genito-Urinary Drugs Product and Services
Table 10. Pfizer Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bayer Basic Information, Manufacturing Base and Competitors
Table 12. Bayer Major Business
Table 13. Bayer Genito-Urinary Drugs Product and Services
Table 14. Bayer Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Astellas Pharma Basic Information, Manufacturing Base and Competitors
Table 16. Astellas Pharma Major Business
Table 17. Astellas Pharma Genito-Urinary Drugs Product and Services
Table 18. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Allergan Basic Information, Manufacturing Base and Competitors
Table 20. Allergan Major Business
Table 21. Allergan Genito-Urinary Drugs Product and Services
Table 22. Allergan Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. GSK Basic Information, Manufacturing Base and Competitors
Table 24. GSK Major Business
Table 25. GSK Genito-Urinary Drugs Product and Services
Table 26. GSK Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Otsuka Pharmaceutical Major Business
Table 29. Otsuka Pharmaceutical Genito-Urinary Drugs Product and Services
Table 30. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Sanofi Basic Information, Manufacturing Base and Competitors
Table 32. Sanofi Major Business
Table 33. Sanofi Genito-Urinary Drugs Product and Services
Table 34. Sanofi Genito-Urinary Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Genito-Urinary Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Genito-Urinary Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Genito-Urinary Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Genito-Urinary Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Genito-Urinary Drugs Production Site of Key Manufacturer
Table 40. Genito-Urinary Drugs New Entrant and Capacity Expansion Plans
Table 41. Genito-Urinary Drugs Mergers & Acquisitions in the Past Five Years
Table 42. Global Genito-Urinary Drugs Sales by Region (2017-2022) & (K Units)
Table 43. Global Genito-Urinary Drugs Sales by Region (2023-2028) & (K Units)
Table 44. Global Genito-Urinary Drugs Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Genito-Urinary Drugs Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 47. Global Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 48. Global Genito-Urinary Drugs Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Genito-Urinary Drugs Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Genito-Urinary Drugs Price by Type (2017-2022) & (USD/Unit)
Table 51. Global Genito-Urinary Drugs Price by Type (2023-2028) & (USD/Unit)
Table 52. Global Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 53. Global Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 54. Global Genito-Urinary Drugs Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Genito-Urinary Drugs Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Genito-Urinary Drugs Price by Application (2017-2022) & (USD/Unit)
Table 57. Global Genito-Urinary Drugs Price by Application (2023-2028) & (USD/Unit)
Table 58. North America Genito-Urinary Drugs Sales by Country (2017-2022) & (K Units)
Table 59. North America Genito-Urinary Drugs Sales by Country (2023-2028) & (K Units)
Table 60. North America Genito-Urinary Drugs Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Genito-Urinary Drugs Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 63. North America Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 64. North America Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 65. North America Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 66. Europe Genito-Urinary Drugs Sales by Country (2017-2022) & (K Units)
Table 67. Europe Genito-Urinary Drugs Sales by Country (2023-2028) & (K Units)
Table 68. Europe Genito-Urinary Drugs Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Genito-Urinary Drugs Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 71. Europe Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 72. Europe Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 73. Europe Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Genito-Urinary Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Genito-Urinary Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Genito-Urinary Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Genito-Urinary Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 82. South America Genito-Urinary Drugs Sales by Country (2017-2022) & (K Units)
Table 83. South America Genito-Urinary Drugs Sales by Country (2023-2028) & (K Units)
Table 84. South America Genito-Urinary Drugs Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Genito-Urinary Drugs Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 87. South America Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 88. South America Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 89. South America Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Genito-Urinary Drugs Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Genito-Urinary Drugs Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Genito-Urinary Drugs Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Genito-Urinary Drugs Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Genito-Urinary Drugs Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Genito-Urinary Drugs Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Genito-Urinary Drugs Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Genito-Urinary Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Genito-Urinary Drugs Raw Material
Table 99. Key Manufacturers of Genito-Urinary Drugs Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Genito-Urinary Drugs Typical Distributors
Table 103. Genito-Urinary Drugs Typical Customers
List of Figures
Figure 1. Genito-Urinary Drugs Picture
Figure 2. Global Genito-Urinary Drugs Revenue Market Share by Type in 2021
Figure 3. OTC
Figure 4. Rx Drugs
Figure 5. Global Genito-Urinary Drugs Revenue Market Share by Application in 2021
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Other
Figure 9. Global Genito-Urinary Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Genito-Urinary Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Genito-Urinary Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Genito-Urinary Drugs Price (2017-2028) & (USD/Unit)
Figure 13. Global Genito-Urinary Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Genito-Urinary Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Genito-Urinary Drugs Market Drivers
Figure 16. Genito-Urinary Drugs Market Restraints
Figure 17. Genito-Urinary Drugs Market Trends
Figure 18. Global Genito-Urinary Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Genito-Urinary Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Genito-Urinary Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Genito-Urinary Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Genito-Urinary Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Genito-Urinary Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Genito-Urinary Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Genito-Urinary Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Genito-Urinary Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Genito-Urinary Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Genito-Urinary Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Genito-Urinary Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Genito-Urinary Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Genito-Urinary Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Genito-Urinary Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 33. Global Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Genito-Urinary Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Genito-Urinary Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. North America Genito-Urinary Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Genito-Urinary Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Genito-Urinary Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Genito-Urinary Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Genito-Urinary Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Genito-Urinary Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Genito-Urinary Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Genito-Urinary Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Genito-Urinary Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Genito-Urinary Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Genito-Urinary Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Genito-Urinary Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Genito-Urinary Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Genito-Urinary Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Genito-Urinary Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Genito-Urinary Drugs in 2021
Figure 77. Manufacturing Process Analysis of Genito-Urinary Drugs
Figure 78. Genito-Urinary Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source